Sonoma Pharmaceuticals Inc (SNOA)

$3.99 +0.18 (4.72%)
Market Cap 6.56M
Revenue (ttm) 14.29M
Net Income (ttm) -3.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.21%
Debt to Equity Ratio 0.00
Volume 35,900
Avg Vol 1,588,274
Day's Range N/A - N/A
Shares Out 1.64M
Stochastic %K 53%
Beta 1.46
Analysts Sell
Price Target $14.80

Company Profile

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild t...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 800 759 9305
Address:
5445 Conestoga Court, Suite 150, Boulder, United States
SimpleLogic85
SimpleLogic85 Oct. 3 at 4:32 PM
$SNOA nooo 🫨
1 · Reply
noname10000
noname10000 Oct. 3 at 4:31 PM
$SNOA nice again
0 · Reply
Bigdubs
Bigdubs Oct. 2 at 11:09 PM
$SNOA Im back in... Ok if goes near 3 Ill continue to buy... It always will be pumped after a new ATM comes out. That Amy likes to use and abuse the P&D.
0 · Reply
SimpleLogic85
SimpleLogic85 Oct. 2 at 8:56 PM
$SNOA 😜
0 · Reply
noname10000
noname10000 Sep. 30 at 10:51 PM
$SNOA time for some news
0 · Reply
noname10000
noname10000 Sep. 30 at 10:15 PM
$SNOA https://www.tipranks.com/news/company-announcements/sonoma-pharmaceuticals-highlights-growth-in-healthcare-sector?utm_source=webullapp.com&utm_medium=referral
0 · Reply
SimpleLogic85
SimpleLogic85 Sep. 29 at 9:24 PM
$SNOA $2 please
0 · Reply
LegendaryCharts
LegendaryCharts Sep. 28 at 4:45 PM
$PAVS Adding to my pre-market watchlist! Started ahuge breakout and could squeeze up more! $JTAI Spac sponsor is bullish $SNOA due for another run $ATNF swing machine
0 · Reply
noname10000
noname10000 Sep. 26 at 9:28 PM
$SNOA give me some cheap ones before the spike
0 · Reply
SimpleLogic85
SimpleLogic85 Sep. 26 at 7:38 PM
$SNOA can this please goes to $2-3
1 · Reply
Latest News on SNOA
Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Sep 25, 2025, 4:01 PM EDT - 9 days ago

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 26, 2025, 8:30 AM EDT - 5 weeks ago

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

Aug 13, 2025, 4:01 PM EDT - 7 weeks ago

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Aug 7, 2025, 4:15 PM EDT - 2 months ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

Jun 17, 2025, 4:10 PM EDT - 3 months ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Apr 22, 2025, 4:01 PM EDT - 5 months ago

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Mar 10, 2025, 4:01 PM EDT - 7 months ago

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Feb 25, 2025, 4:01 PM EST - 7 months ago

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Feb 5, 2025, 4:05 PM EST - 8 months ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Dec 5, 2024, 8:30 AM EST - 10 months ago

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Nov 21, 2024, 4:06 PM EST - 11 months ago

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Nov 11, 2024, 4:20 PM EST - 11 months ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Nov 7, 2024, 8:45 AM EST - 11 months ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Oct 31, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Oct 22, 2024, 8:35 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Oct 21, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sep 19, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Sep 11, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Aug 28, 2024, 6:10 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Aug 26, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Aug 21, 2024, 8:45 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Jul 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

Jun 17, 2024, 5:00 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

May 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Apr 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Mar 28, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Mar 27, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Feb 8, 2024, 4:10 PM EST - 1 year ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

Jan 23, 2024, 7:30 AM EST - 1 year ago

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

Jan 9, 2024, 9:15 AM EST - 1 year ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

NBY

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Nov 13, 2023, 4:10 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Nov 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

Oct 26, 2023, 9:10 AM EDT - 2 years ago

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 15, 2023, 7:30 AM EDT - 2 years ago

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

Aug 10, 2023, 4:15 PM EDT - 2 years ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results

Jun 22, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results

Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product

Jun 9, 2023, 5:05 PM EDT - 2 years ago

Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product

Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union

Jun 8, 2023, 4:01 PM EDT - 2 years ago

Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union

Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care

Apr 11, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia

Mar 28, 2023, 4:15 PM EDT - 2 years ago

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia

Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant

Mar 2, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant

Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results

Feb 14, 2023, 4:30 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

Jan 31, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products

Jan 25, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products

Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas

Jan 4, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas

Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results

Nov 14, 2022, 4:15 PM EST - 3 years ago

Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results

SimpleLogic85
SimpleLogic85 Oct. 3 at 4:32 PM
$SNOA nooo 🫨
1 · Reply
noname10000
noname10000 Oct. 3 at 4:31 PM
$SNOA nice again
0 · Reply
Bigdubs
Bigdubs Oct. 2 at 11:09 PM
$SNOA Im back in... Ok if goes near 3 Ill continue to buy... It always will be pumped after a new ATM comes out. That Amy likes to use and abuse the P&D.
0 · Reply
SimpleLogic85
SimpleLogic85 Oct. 2 at 8:56 PM
$SNOA 😜
0 · Reply
noname10000
noname10000 Sep. 30 at 10:51 PM
$SNOA time for some news
0 · Reply
noname10000
noname10000 Sep. 30 at 10:15 PM
$SNOA https://www.tipranks.com/news/company-announcements/sonoma-pharmaceuticals-highlights-growth-in-healthcare-sector?utm_source=webullapp.com&utm_medium=referral
0 · Reply
SimpleLogic85
SimpleLogic85 Sep. 29 at 9:24 PM
$SNOA $2 please
0 · Reply
LegendaryCharts
LegendaryCharts Sep. 28 at 4:45 PM
$PAVS Adding to my pre-market watchlist! Started ahuge breakout and could squeeze up more! $JTAI Spac sponsor is bullish $SNOA due for another run $ATNF swing machine
0 · Reply
noname10000
noname10000 Sep. 26 at 9:28 PM
$SNOA give me some cheap ones before the spike
0 · Reply
SimpleLogic85
SimpleLogic85 Sep. 26 at 7:38 PM
$SNOA can this please goes to $2-3
1 · Reply
SimpleLogic85
SimpleLogic85 Sep. 24 at 4:24 PM
$SNOA come on $3
0 · Reply
SimpleLogic85
SimpleLogic85 Sep. 23 at 8:50 PM
$SNOA go ahead and goes to $2 please
0 · Reply
codyfrazier777
codyfrazier777 Sep. 15 at 8:15 PM
$SNOA patiently waiting and buying more. this will be an epic squeeze.
1 · Reply
codyfrazier777
codyfrazier777 Sep. 15 at 12:30 PM
$SNOA cant wait for the squeeze im continuing to buy at a discount
0 · Reply
paramania
paramania Sep. 13 at 2:27 AM
$SNOA beautiful bullish stack for a swing
0 · Reply
MMW_
MMW_ Sep. 11 at 4:50 PM
$SNOA to the shorts 🩳. You should cover soon before it pop 1,000% in a span of 5 mins pre market like the recent trends. Dont blow up.
0 · Reply
EfficientMarketer
EfficientMarketer Sep. 10 at 11:44 PM
$SNOA 1.6M float at the top of the high SI list. Should squeeze hard off $OPEN move
0 · Reply
Jitbag22
Jitbag22 Sep. 10 at 8:59 PM
$SNOA 67 🤲
1 · Reply
RetireB4FortyX
RetireB4FortyX Sep. 10 at 2:06 PM
$SNOA crazy amount of days to cover here for shorts
0 · Reply
MMW_
MMW_ Sep. 9 at 8:52 PM
$SNOA fades into red
0 · Reply
GluttonBoy
GluttonBoy Sep. 9 at 5:38 PM
TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play Watching these too- $SNOA $AXIL $TANH $MTEK $SELX !
0 · Reply
noname10000
noname10000 Sep. 8 at 4:50 PM
$SNOA why red?
0 · Reply